THE AMERICAN ASSOCIATION for Cancer Research (AACR) recently announced its newly elected class of Fellows of the AACR Academy. The mission of the AACR Academy is to recognize and honor distinguished scientists whose major scientific contributions have propelled significant innovation and progress against cancer, with the goal of preventing and curing cancers through research, education, communication, and collaboration. All Fellows are nominated and elected through an annual peer-review process conducted by existing Fellows of the AACR Academy and ratified by the AACR Executive Committee.
Newly Elected 2018 Fellows
- Alan Ashworth, PhD, FRS, of the UCSF Helen Diller Family Comprehensive Cancer Center
- René Bernards, DPhil, of the Netherlands Cancer Institute, Amsterdam
- Bruce A. Beutler, MD, of The University of Texas Southwestern Medical Center, Dallas
- Michael A. Caligiuri, MD, of The City of Hope National Medical Center, Duarte, California
- Chi Van Dang, MD, PhD, of the Ludwig Institute for Cancer Research, New York, and The Wistar Institute, Philadelphia
- Gary Gilliland, MD, PhD, of the Fred Hutchinson Cancer Research Center, Seattle
- Laurie H. Glimcher, MD, of the Dana-Farber Cancer Institute, Boston
- Elizabeth M. Jaffee, MD, of the Sidney Kimmel Comprehensive Cancer Center and The Johns Hopkins University School of Medicine, Baltimore
- Richard D. Klausner, MD, Founder and Director, Juno Therapeutics; Founder and Director, GRAIL; Executive Chairman, Wisdo; Co-Founder and Executive Chairman, Mindstrong, Los Altos Hills, California
- Roger D. Kornberg, PhD, of Stanford University School of Medicine, Stanford, California
- Arthur D. Levinson, PhD, Founder and Chief Executive Officer, Calico Life Sciences LLC, South San Francisco, California
- Norman E. Sharpless, MD, Director of National Cancer Institute, Bethesda, Maryland. ■
